Furthermore, IKKβ targeting reduces EMT and metastasis in a colorectal mouse model of tumour progression [51] and reduces oral squamous carcinoma and prostate cancer cell invasion [52]. This evidence concerns the gene IKBKB and prostate carcinoma.